December 4, 2022
You are here:  Home  >  Regions  >  East Ventura County  >  Current Article

FDA approves biosimilar competitor to Amgen’s Enbrel


The Food and Drug Administration has approved a second biosimilar competitor for Amgen’s blockbuster rheumatoid arthritis drug Enbrel. Korean biopharmaceutical company Samsung Bioepis’ biosimilar, called Eticovo, was approved to treat all the conditions treated by Enbrel. Amgen’s top-selling drug, Enbrel brought in just over $5 billion for the Thousand Oaks biotech giant in 2018, down…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.